ECP 2023 Final Programme

Monday, 11 Sept 186 e Monday, 11 September 2023 BRS-01 Industry Symposium 07:15–08:15 Liffey Hall 1 Computational pathology: enhancing human capabilities to transform cancer diagnostics (AstraZeneca) Chair: Jessica Baumann, USA 001 07:15–07:20 Welcome and introductions Jessica Baumann, USA 002 07:20–07:30 Quantitative Continous Scoring: a new frontier in diagnostics Christian Eisen, Germany 003 07:30–07:45 Discussion and Q&A (All Faculty) Jessica Baumann, USA 004 07:45–07:55 Pathology at the frontier: preparing for new opportunities in practice Bethany Williams, United Kingdom 005 07:55–08:15 Discussion and Q&A (All Faculty) Jessica Baumann, USA BRS-02 Industry Symposium 07:15–08:15 Wicklow Hall 1 Unlocking Precision Oncology Insights with Decentralized NGS Data Analysis (Sophia Genetics) Chair: Philippe Menu, Switzerland 001 Decentralizing collective intelligence in precision oncology Philippe Menu, Switzerland 002 Analytical performance of CNV calling prototype for Homologous Recombination Deficiency (HRD) detection Angelo Minucci, Italy 003 The impact of NGS molecular profiling in Chronic Lymphocytic Leukemia (CLL) Dolores Colomer, Spain LS-07 Industry Symposium 13:00–14:30 Liffey A Unleashing the power of molecular testing: Liquid biopsy and comprehen- sive genomic profiling in precision oncology (Thermo Fisher) Chairs: Javier Hernandez Losa, Spain Francesco Passiglia, Italy 001 13:00–13:05 Welcome and Introduction Javier Hernandez Losa, Spain Francesco Passiglia, Italy 002 13:05–13:17 ISO15189 Next generation gequencing testing at Cork University Hospital Reiltin Werner, Ireland 003 13:17–13:45 Feasibility study: comparing tissue and blood profiles at baseline for the identifica- tion of genomic alterations Simonetta Buglioni, Italy 004 13:45–14:05 Exploring the Impact of comprehensive genomic profiling in solid tumor testing Gorka Alkorta-Aranburu, Spain 005 14:05–14:25 Ovarian cancer testing: unveil Homologous Recombination Deficiency (HRD) through CGP NGS analysis Annette Staebler, Germany 006 14:25–14:30 Q&A All faculty LS-08 Industry Symposium 13:00–14:30 Wicklow Hall 1 No patient left behind: Importance of Comprehensive Genomic Profiling (CGP) and incorporating rare biomarkers into your practice (Illumina & Bayer) Chairs: Caterina Marchiò, Italy Nicola Normanno, Italy 001 13:00–13:03 Welcoming Remarks Caterina Marchiò, Italy Industry Symposia